Please provide your email address to receive an email when new articles are posted on . Corneal cross-linking should be considered as a viable treatment for patients of all ages with keratoconus due ...

Please provide your email address to receive an email when new articles are posted on . Patient registries have shown that PK rates for keratoconus decreased after the introduction of cross-linking.

A study published in Ophthalmology and Therapy found that Epioxa, an epithelium-on corneal collagen cross-linking treatment, ...

Myopia, or short-sightedness, is almost twice as common in the US and Europe today than it was 50 years ago. It has also become an important problem in some Eastern Asian countries where it affects as ...

Prior to the mainstream introduction of corneal collagen cross-linking (CXL) in the late 2000s, there was no effective treatment to prevent progression of keratoconus, other than corneal grafting ...

"Corneal cross-linking is beneficial to my patients in that if offers them a therapeutic option to limit the progression of keratoconus," says Dr. Mitchel Jackson. "The FDA approval of corneal ...

SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...

While I congratulate the Journal for encouraging such interesting debates and the authors for their hard work in presenting their points of view, I feel it is necessary to point out two inaccuracies ...